Trials / Completed
CompletedNCT02841007
Midds Ankle Fracture
gekoTM Neuromuscular Electrostimulation (NMES) Device, Pilot Feasibility Study Looking at Time to Surgery Study in Patients Requiring Ankle Fixation Following Fracture, Comparison to Matched Retrospective Controls
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Firstkind Ltd · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The geko™ device is indicated for the prevention and treatment of oedema. The aim of this study is to show that recruiting, and performing study assessments in ankle fracture patients requiring surgery to fix their ankle attending the James Cook Hospital is feasible, and to obtain data to support the powering of a larger study to demonstrate the effectiveness of the geko™ device at reducing length of stay for this population of patients. This study will also allow us to assess the acceptability, tolerability and compliance of treatment with the geko device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | geko neuromuscular electrostimulation device |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2016-07-21
- Last updated
- 2017-04-13
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02841007. Inclusion in this directory is not an endorsement.